Cargando…

Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland

BACKGROUND: Overdiagnosis is the most important adverse event of breast cancer screening with the estimates ranging from 0% to 40–50% depending on invitational age and methods. We updated the estimates of overdiagnosis in Helsinki service screening study in Finland by comparing the observed and expe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinävaara, S, Sarkeala, T, Anttila, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183845/ https://www.ncbi.nlm.nih.gov/pubmed/25121953 http://dx.doi.org/10.1038/bjc.2014.413

Ejemplares similares

Impact of organised mammography screening on breast cancer mortality in a case–control and cohort study
por: Heinävaara, Sirpa, et al.
Publicado: (2016)

Breast cancer mortality with varying invitational policies in organised mammography
por: Sarkeala, T, et al.
Publicado: (2008)

Complexities in the estimation of overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2008)

Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland
por: Sarkeala, Tytti, et al.
Publicado: (2021)

Impacts of the Finnish service screening programme on breast cancer rates
por: Anttila, Ahti, et al.
Publicado: (2008)

Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland
por: Pitkäniemi, J, et al.
Publicado: (2015)

Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening
por: Paci, Eugenio, et al.
Publicado: (2005)

Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976–2009
por: Parvinen, I, et al.
Publicado: (2015)

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
por: Pashayan, N, et al.
Publicado: (2009)

A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain
por: Waller, J, et al.
Publicado: (2014)

Effectiveness of cervical cancer screening at age 65 — A register-based cohort study
por: Pankakoski, Maiju, et al.
Publicado: (2019)

Health inequalities among Russian-born immigrant women in Finland: Longitudinal analysis on cervical cancer incidence and participation in screening
por: Lamminmäki, Maarit, et al.
Publicado: (2022)

High lifetime probability of screen-detected cervical abnormalities
por: Pankakoski, Maiju, et al.
Publicado: (2017)

Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
por: Pathirana, Thanya, et al.
Publicado: (2019)

Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis
por: Zahl, P-H, et al.
Publicado: (2013)

Effectiveness of Cervical Testing in and outside a Screening Program—A Case-Control Study
por: Pankakoski, Maiju, et al.
Publicado: (2022)

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia
por: Pashayan, N, et al.
Publicado: (2006)

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
por: Leinonen, M K, et al.
Publicado: (2013)

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography
por: Jacklyn, Gemma, et al.
Publicado: (2016)

Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer
por: Duffy, Stephen W, et al.
Publicado: (2005)

Overdiagnosis among women attending a population-based mammography screening program
por: Falk, Ragnhild Sørum, et al.
Publicado: (2013)

Estimation of lead time and overdiagnosis in breast cancer screening
por: Gøtzsche, P C, et al.
Publicado: (2009)

Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy
por: Paci, Eugenio, et al.
Publicado: (2006)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010
por: Luoto, R, et al.
Publicado: (2004)

Overdiagnosis and breast cancer screening
por: Day, Nick E
Publicado: (2005)

Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom
por: Gunsoy, N B, et al.
Publicado: (2014)

Reply: Estimation of lead-time and overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2009)

Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening
por: Moss, Sue
Publicado: (2005)

Overdiagnosis across medical disciplines: a scoping review
por: Jenniskens, Kevin, et al.
Publicado: (2017)

The green view dataset for the capital of Finland, Helsinki
por: Toikka, Akseli, et al.
Publicado: (2020)

Overestimating Overdiagnosis in Breast Cancer Screening
por: Hollingsworth, Alan
Publicado: (2017)

Mortality benefits and overdiagnosis estimates for women attending breast screening
por: Ormiston-Smith, N, et al.
Publicado: (2013)

Heat, Heatwaves and Cardiorespiratory Hospital Admissions in Helsinki, Finland
por: Sohail, Hasan, et al.
Publicado: (2020)

Overdiagnosis and overtreatment of breast cancer: Is overdiagnosis an issue for radiologists?
por: Warren, Ruth, et al.
Publicado: (2006)

Flexible transition probability model for assessing cost-effectiveness of breast cancer screening extension to include women aged 45-49 and 70-74
por: Shafik, Nourhan, et al.
Publicado: (2023)

Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?
por: Chaltiel, Dan, et al.
Publicado: (2021)

Overdiagnosis in lung cancer screening
por: Yankelevitz, David F., et al.
Publicado: (2021)

Genomic epidemiology of nosocomial carbapenemase-producing Citrobacter freundii in sewerage systems in the Helsinki metropolitan area, Finland
por: Heljanko, Viivi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8re9o1hndla9bc6amvh2ci101c